Summary:
American Institute of Research is currently conducting a Phase 4, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB)
Qualified Participants Must:
Be 65 years of age or older
Be willing and able to complete the micturition diary and questionnaires correctly
Have symptoms of wet OAB (urinary frequency and urgency with incontinence) for greater than or equal to 3 months
Qualified Participants May Receive:
All study related exams and medications will be provided to you at no cost. Participants may also receive compensation for their time and travel.